-
1
-
-
84872378144
-
3 receptor availability is inversely correlated with cannabis consumption in chronic marijuana users
-
3 receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. Drug Alcohol Depend. 2013, 128:52-57. 10.1016/j.drugalcdep.2012.07.016.
-
(2013)
Drug Alcohol Depend.
, vol.128
, pp. 52-57
-
-
Albrecht, D.S.1
Skosnik, P.D.2
Vollmer, J.M.3
Brumbaugh, M.S.4
Perry, K.M.5
Mock, B.H.6
Zheng, Q.H.7
Federici, L.A.8
Patton, E.A.9
Herring, C.M.10
Yoder, K.K.11
-
2
-
-
0000735519
-
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
-
Andréasson S., Allebeck P., Engström A., Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987, 2:1483-1486. 10.1016/S0140-6736(87)92620-1.
-
(1987)
Lancet
, vol.2
, pp. 1483-1486
-
-
Andréasson, S.1
Allebeck, P.2
Engström, A.3
Rydberg, U.4
-
3
-
-
0442307621
-
Causal association between cannabis andpsychosis: examinationof the evidence
-
Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis andpsychosis: examinationof the evidence. Br. J. Psychiatry 2004, 184:110-117. 10.1192/bjp.184.2.110.
-
(2004)
Br. J. Psychiatry
, vol.184
, pp. 110-117
-
-
Arseneault, L.1
Cannon, M.2
Witton, J.3
Murray, R.M.4
-
4
-
-
0016699656
-
Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes
-
Banerjee S.P., Snyder S.H., Mechoulam R. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. J. Pharmacol. Exp. Ther. 1975, 194:74-81.
-
(1975)
J. Pharmacol. Exp. Ther.
, vol.194
, pp. 74-81
-
-
Banerjee, S.P.1
Snyder, S.H.2
Mechoulam, R.3
-
5
-
-
0034748234
-
The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders
-
Bannon M.J., Michelhaugh S.K., Wang J., Sacchetti P. The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur. Neuropsychopharmacol. 2001, 11:449-455.
-
(2001)
Eur. Neuropsychopharmacol.
, vol.11
, pp. 449-455
-
-
Bannon, M.J.1
Michelhaugh, S.K.2
Wang, J.3
Sacchetti, P.4
-
6
-
-
65249140612
-
The catechol-O-methyl transferase Val158Met polymorphism and susceptibility to cannabis dependence
-
Baransel Isir A.B., Oguzkan S., Nacak M., Gorucu S., Dulger H.E., Arslan A. The catechol-O-methyl transferase Val158Met polymorphism and susceptibility to cannabis dependence. Am. J. Forensic Med. Pathol. Off. Publ. Natl. Assoc. Med. Exam 2008, 29:320-322. 10.1097/PAF.0b013e3181847e56.
-
(2008)
Am. J. Forensic Med. Pathol. Off. Publ. Natl. Assoc. Med. Exam
, vol.29
, pp. 320-322
-
-
Baransel Isir, A.B.1
Oguzkan, S.2
Nacak, M.3
Gorucu, S.4
Dulger, H.E.5
Arslan, A.6
-
7
-
-
82955215765
-
Does intravenous 9-tetrahydrocannabinol increase dopamine release? A SPET study
-
Barkus E., Morrison P.D., Vuletic D., Dickson J.C., Ell P.J., Pilowsky L.S., Brenneisen R., Holt D.W., Powell J., Kapur S., Murray R.M. Does intravenous 9-tetrahydrocannabinol increase dopamine release? A SPET study. J. Psychopharmacol 2011, 25:1462-1468. 10.1177/0269881110382465.
-
(2011)
J. Psychopharmacol
, vol.25
, pp. 1462-1468
-
-
Barkus, E.1
Morrison, P.D.2
Vuletic, D.3
Dickson, J.C.4
Ell, P.J.5
Pilowsky, L.S.6
Brenneisen, R.7
Holt, D.W.8
Powell, J.9
Kapur, S.10
Murray, R.M.11
-
8
-
-
79961220783
-
Adding tobacco to cannabis-its frequency and likely implications
-
Bélanger R.E., Akre C., Kuntsche E., Gmel G., Suris J.C. Adding tobacco to cannabis-its frequency and likely implications. Nicotine Tob. Res. 2011, 13:746-750. 10.1093/ntr/ntr043.
-
(2011)
Nicotine Tob. Res.
, vol.13
, pp. 746-750
-
-
Bélanger, R.E.1
Akre, C.2
Kuntsche, E.3
Gmel, G.4
Suris, J.C.5
-
9
-
-
84870053882
-
Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function
-
Bhattacharyya S., Atakan Z., Martin-Santos R., Crippa J.a, Kambeitz J., Prata D., Williams S., Brammer M., Collier D.a, McGuire P.K. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function. Mol. Psychiatry 2012, 17:1152-1155. 10.1038/mp.2011.187.
-
(2012)
Mol. Psychiatry
, vol.17
, pp. 1152-1155
-
-
Bhattacharyya, S.1
Atakan, Z.2
Martin-Santos, R.3
Crippa, J.A.4
Kambeitz, J.5
Prata, D.6
Williams, S.7
Brammer, M.8
Collier, D.A.9
McGuire, P.K.10
-
10
-
-
84855316451
-
Induction of psychosis by δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing
-
Bhattacharyya S., Crippa J.A., Allen P., Martin-Santos R., Borgwardt S., Fusar-Poli P., Rubia K., Kambeitz J., O'Carroll C., Seal M.L., Giampietro V., Brammer M., Zuardi A.W., Atakan Z., McGuire P.K. Induction of psychosis by δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch. Gen. Psychiatry 2012, 69:27-36. 10.1001/archgenpsychiatry.2011.161.
-
(2012)
Arch. Gen. Psychiatry
, vol.69
, pp. 27-36
-
-
Bhattacharyya, S.1
Crippa, J.A.2
Allen, P.3
Martin-Santos, R.4
Borgwardt, S.5
Fusar-Poli, P.6
Rubia, K.7
Kambeitz, J.8
O'Carroll, C.9
Seal, M.L.10
Giampietro, V.11
Brammer, M.12
Zuardi, A.W.13
Atakan, Z.14
McGuire, P.K.15
-
11
-
-
64849106877
-
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis
-
Bhattacharyya S., Fusar-Poli P., Borgwardt S., Martin-Santos R., Nosarti C., O'Carroll C., Allen P., Seal M.L., Fletcher P.C., Crippa J.A., Giampietro V., Mechelli A., Atakan Z., McGuire P. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch. Gen. Psychiatry 2009, 66:442-451. 10.1001/archgenpsychiatry.2009.17.
-
(2009)
Arch. Gen. Psychiatry
, vol.66
, pp. 442-451
-
-
Bhattacharyya, S.1
Fusar-Poli, P.2
Borgwardt, S.3
Martin-Santos, R.4
Nosarti, C.5
O'Carroll, C.6
Allen, P.7
Seal, M.L.8
Fletcher, P.C.9
Crippa, J.A.10
Giampietro, V.11
Mechelli, A.12
Atakan, Z.13
McGuire, P.14
-
12
-
-
84927697830
-
Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control
-
Bhattacharyya S., Iyegbe C., Atakan Z., Martin-Santos R., Crippa J.a, Xu X., Williams S., Brammer M., Rubia K., Prata D., Collier D.a, McGuire P.K. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control. Psychol. Med 2014, 44:3315-3328. 10.1017/S0033291714000920.
-
(2014)
Psychol. Med
, vol.44
, pp. 3315-3328
-
-
Bhattacharyya, S.1
Iyegbe, C.2
Atakan, Z.3
Martin-Santos, R.4
Crippa, J.A.5
Xu, X.6
Williams, S.7
Brammer, M.8
Rubia, K.9
Prata, D.10
Collier, D.A.11
McGuire, P.K.12
-
14
-
-
84894479797
-
Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms
-
Bloomfield M.A.P., Morgan C.J.A., Egerton A., Kapur S., Curran H.V., Howes O.D. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol. Psychiatry 2014, 75:470-478. 10.1016/j.biopsych.2013.05.027.
-
(2014)
Biol. Psychiatry
, vol.75
, pp. 470-478
-
-
Bloomfield, M.A.P.1
Morgan, C.J.A.2
Egerton, A.3
Kapur, S.4
Curran, H.V.5
Howes, O.D.6
-
15
-
-
84900854828
-
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study
-
Bloomfield M.A.P., Morgan C.J.A., Kapur S., Curran H.V., Howes O.D. The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study. Psychopharmacology 2014, 231:2251-2259. 10.1007/s00213-014-3523-4.
-
(2014)
Psychopharmacology
, vol.231
, pp. 2251-2259
-
-
Bloomfield, M.A.P.1
Morgan, C.J.A.2
Kapur, S.3
Curran, H.V.4
Howes, O.D.5
-
16
-
-
58149477877
-
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum
-
Bossong M.G., van Berckel B.N.M., Boellaard R., Zuurman L., Schuit R.C., Windhorst A.D., van Gerven J.M.A., Ramsey N.F., Lammertsma A.A., Kahn R.S. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 2009, 34:759-766. 10.1038/npp.2008.138.
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 759-766
-
-
Bossong, M.G.1
van Berckel, B.N.M.2
Boellaard, R.3
Zuurman, L.4
Schuit, R.C.5
Windhorst, A.D.6
van Gerven, J.M.A.7
Ramsey, N.F.8
Lammertsma, A.A.9
Kahn, R.S.10
-
17
-
-
35748974202
-
Elevated plasma dopamine metabolites in cannabis psychosis
-
Bowers M.B., Kantrowitz J.T. Elevated plasma dopamine metabolites in cannabis psychosis. Am. J. Psychiatry 2007, 10.1176/appi.ajp.2007.07010217.
-
(2007)
Am. J. Psychiatry
-
-
Bowers, M.B.1
Kantrowitz, J.T.2
-
18
-
-
12644293806
-
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method
-
Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. USA 1997, 94:2569-2574. 10.1073/pnas.94.6.2569.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 2569-2574
-
-
Breier, A.1
Su, T.P.2
Saunders, R.3
Carson, R.E.4
Kolachana, B.S.5
de Bartolomeis, A.6
Weinberger, D.R.7
Weisenfeld, N.8
Malhotra, A.K.9
Eckelman, W.C.10
Pickar, D.11
-
19
-
-
0034706069
-
Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study
-
Cheer J.F., Marsden C.A., Kendall D.A., Mason R. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience 2000, 99:661-667. 10.1016/S0306-4522(00)00241-4.
-
(2000)
Neuroscience
, vol.99
, pp. 661-667
-
-
Cheer, J.F.1
Marsden, C.A.2
Kendall, D.A.3
Mason, R.4
-
20
-
-
2342668029
-
Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats
-
Cheer J.F., Wassum K.M., Heien M.L.A.V, Phillips P.E.M., Wightman R.M. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J. Neurosci. 2004, 24:4393-4400. 10.1523/JNEUROSCI.0529-04.2004.
-
(2004)
J. Neurosci.
, vol.24
, pp. 4393-4400
-
-
Cheer, J.F.1
Wassum, K.M.2
Heien, M.L.A.V.3
Phillips, P.E.M.4
Wightman, R.M.5
-
21
-
-
0025161255
-
δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis
-
Chen J., Paredes W., Li J., Smith D., Lowinson J., Gardner E.L. δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 1990, 102:156-162. 10.1007/BF02245916.
-
(1990)
Psychopharmacology
, vol.102
, pp. 156-162
-
-
Chen, J.1
Paredes, W.2
Li, J.3
Smith, D.4
Lowinson, J.5
Gardner, E.L.6
-
22
-
-
15744398700
-
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction
-
D'Souza D.C., Abi-Saab W.M., Madonick S., Forselius-Bielen K., Doersch A., Braley G., Gueorguieva R., Cooper T.B., Krystal J.H. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol. Psychiatry 2005, 57:594-608. 10.1016/j.biopsych.2004.12.006.
-
(2005)
Biol. Psychiatry
, vol.57
, pp. 594-608
-
-
D'Souza, D.C.1
Abi-Saab, W.M.2
Madonick, S.3
Forselius-Bielen, K.4
Doersch, A.5
Braley, G.6
Gueorguieva, R.7
Cooper, T.B.8
Krystal, J.H.9
-
23
-
-
3242789385
-
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis
-
D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.-T., Braley G., Gueorguieva R., Krystal J.H. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2004, 10.1038/sj.npp.1300496.
-
(2004)
Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol.
-
-
D'Souza, D.C.1
Perry, E.2
MacDougall, L.3
Ammerman, Y.4
Cooper, T.5
Wu, Y.-T.6
Braley, G.7
Gueorguieva, R.8
Krystal, J.H.9
-
24
-
-
44549087417
-
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis
-
D'Souza D.C., Ranganathan M., Braley G., Gueorguieva R., Zimolo Z., Cooper T., Perry E., Krystal J. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology 2008, 33:2505-2516. 10.1038/sj.npp.1301643.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 2505-2516
-
-
D'Souza, D.C.1
Ranganathan, M.2
Braley, G.3
Gueorguieva, R.4
Zimolo, Z.5
Cooper, T.6
Perry, E.7
Krystal, J.8
-
25
-
-
84889080215
-
Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions
-
Davis G.P., Compton M.T., Wang S., Levin F.R., Blanco C. Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr. Res. 2013, 151:197-202. 10.1016/j.schres.2013.10.018.
-
(2013)
Schizophr. Res.
, vol.151
, pp. 197-202
-
-
Davis, G.P.1
Compton, M.T.2
Wang, S.3
Levin, F.R.4
Blanco, C.5
-
26
-
-
0026070134
-
Dopamine in schizophrenia: a review and reconceptualization
-
doi:1681750
-
Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 1991, 148:1474-1486. doi:1681750.
-
(1991)
Am. J. Psychiatry
, vol.148
, pp. 1474-1486
-
-
Davis, K.L.1
Kahn, R.S.2
Ko, G.3
Davidson, M.4
-
27
-
-
0037382707
-
Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia
-
Dean B., Bradbury R., Copolov D.L. Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia. Biol. Psychiatry 2003, 53:585-592. 10.1016/S0006-3223(02)01545-7.
-
(2003)
Biol. Psychiatry
, vol.53
, pp. 585-592
-
-
Dean, B.1
Bradbury, R.2
Copolov, D.L.3
-
28
-
-
84886266151
-
The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study
-
PLoS One 8.
-
Degenhardt, L., Ferrari, A.J., Calabria, B., Hall, W.D., Norman, R.E., McGrath, J., Flaxman, A.D., Engell, R.E., Freedman, G.D., Whiteford, H.A., Vos, T., 2013. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS One 8. 10.1371/journal.pone.0076635.
-
(2013)
-
-
Degenhardt, L.1
Ferrari, A.J.2
Calabria, B.3
Hall, W.D.4
Norman, R.E.5
McGrath, J.6
Flaxman, A.D.7
Engell, R.E.8
Freedman, G.D.9
Whiteford, H.A.10
Vos, T.11
-
29
-
-
84867743306
-
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
-
Di Forti M., Iyegbe C., Sallis H., Kolliakou A., Falcone M.A., Paparelli A., Sirianni M., La Cascia C., Stilo S.A., Marques T.R., Handley R., Mondelli V., Dazzan P., Pariante C., David A.S., Morgan C., Powell J., Murray R.M. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol. Psychiatry 2012, 72:811-816. 10.1016/S0006-3223(02)01545-7.
-
(2012)
Biol. Psychiatry
, vol.72
, pp. 811-816
-
-
Di Forti, M.1
Iyegbe, C.2
Sallis, H.3
Kolliakou, A.4
Falcone, M.A.5
Paparelli, A.6
Sirianni, M.7
La Cascia, C.8
Stilo, S.A.9
Marques, T.R.10
Handley, R.11
Mondelli, V.12
Dazzan, P.13
Pariante, C.14
David, A.S.15
Morgan, C.16
Powell, J.17
Murray, R.M.18
-
30
-
-
0035863035
-
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
-
Drevets W.C., Gautier C., Price J.C., Kupfer D.J., Kinahan P.E., Grace A.A., Price J.L., Mathis C.A. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry 2001, 49:81-96. 10.1016/S0006-3223(00)01038-6.
-
(2001)
Biol. Psychiatry
, vol.49
, pp. 81-96
-
-
Drevets, W.C.1
Gautier, C.2
Price, J.C.3
Kupfer, D.J.4
Kinahan, P.E.5
Grace, A.A.6
Price, J.L.7
Mathis, C.A.8
-
31
-
-
84906077179
-
Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity
-
Faure P., Tolu S., Valverde S., Naudé J. Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity. Neuroscience 2014, 10.1016/j.neuroscience.2014.05.040.
-
(2014)
Neuroscience
-
-
Faure, P.1
Tolu, S.2
Valverde, S.3
Naudé, J.4
-
32
-
-
0030887785
-
Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
-
French E.D., Dillon K., Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 1997, 8:649-652. 10.1097/00001756-199702100-00014.
-
(1997)
Neuroreport
, vol.8
, pp. 649-652
-
-
French, E.D.1
Dillon, K.2
Wu, X.3
-
33
-
-
20444398090
-
Endocannabinoid signaling system and brain reward: emphasis on dopamine
-
Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol. Biochem. Behav. 2005, 263-284. 10.1016/j.pbb.2005.01.032.
-
(2005)
Pharmacol. Biochem. Behav.
, pp. 263-284
-
-
Gardner, E.L.1
-
35
-
-
0030973808
-
Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices
-
Gifford A.N., Samiian L., Gatley S.J., Ashby C.R. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices. Eur. J. Pharmacol. 1997, 324:187-192.
-
(1997)
Eur. J. Pharmacol.
, vol.324
, pp. 187-192
-
-
Gifford, A.N.1
Samiian, L.2
Gatley, S.J.3
Ashby, C.R.4
-
36
-
-
33646078787
-
Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography
-
Ginovart N., Galineau L., Willeit M., Mizrahi R., Bloomfield P.M., Seeman P., Houle S., Kapur S., Wilson A.A. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. J. Neurochem. 2006, 97:1089-1103. 10.1111/j.1471-4159.2006.03840.x.
-
(2006)
J. Neurochem.
, vol.97
, pp. 1089-1103
-
-
Ginovart, N.1
Galineau, L.2
Willeit, M.3
Mizrahi, R.4
Bloomfield, P.M.5
Seeman, P.6
Houle, S.7
Kapur, S.8
Wilson, A.A.9
-
37
-
-
84866430898
-
Chronic δ9-tetrahydrocannabinol exposure induces a sensitization of dopamine D2/3 receptors in the mesoaccumbens and nigrostriatal systems
-
Ginovart N., Tournier B.B., Moulin-Sallanon M., Steimer T., Ibanez V., Millet P. Chronic δ9-tetrahydrocannabinol exposure induces a sensitization of dopamine D2/3 receptors in the mesoaccumbens and nigrostriatal systems. Neuropsychopharmacology 2012, 10.1038/npp.2012.91.
-
(2012)
Neuropsychopharmacology
-
-
Ginovart, N.1
Tournier, B.B.2
Moulin-Sallanon, M.3
Steimer, T.4
Ibanez, V.5
Millet, P.6
-
38
-
-
49649121541
-
Impact of cannabis and other drugs on age at onset of psychosis
-
González-Pinto A., Vega P., Ibáñez B., Mosquera F., Barbeito S., Gutiérrez M., Azúa Ruiz De, Ruiz S., Vieta, E.I. Impact of cannabis and other drugs on age at onset of psychosis. J. Clin. Psychiatry 2008, 69:1210-1216. 10.4088/JCP.v69n0802.
-
(2008)
J. Clin. Psychiatry
, vol.69
, pp. 1210-1216
-
-
González-Pinto, A.1
Vega, P.2
Ibáñez, B.3
Mosquera, F.4
Barbeito, S.5
Gutiérrez, M.6
Azúa, R.D.7
Ruiz, S.8
Vieta, E.I.9
-
39
-
-
0034142232
-
Genotype influences in vivo dopamine transporter availability in human striatum
-
Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., Lee K.S., Linnoila M., Weinberger D.R. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000, 22:133-139. 10.1016/S0893-133X(99)00099-8.
-
(2000)
Neuropsychopharmacology
, vol.22
, pp. 133-139
-
-
Heinz, A.1
Goldman, D.2
Jones, D.W.3
Palmour, R.4
Hommer, D.5
Gorey, J.G.6
Lee, K.S.7
Linnoila, M.8
Weinberger, D.R.9
-
40
-
-
33751119258
-
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition
-
Henquet C., Rosa A., Krabbendam L., Papiol S., Fananás L., Drukker M., Ramaekers J.G., van Os J. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006, 31:2748-2757. 10.1038/sj.npp.1301197.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 2748-2757
-
-
Henquet, C.1
Rosa, A.2
Krabbendam, L.3
Papiol, S.4
Fananás, L.5
Drukker, M.6
Ramaekers, J.G.7
van Os, J.8
-
41
-
-
13244256818
-
Cerebrovascular perfusion in marijuana users during a month of monitored abstinence
-
Herning R.I., Better W.E., Tate K., Cadet J.L Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology 2005, 64:488-493. 10.1212/WNL.65.7.1145.
-
(2005)
Neurology
, vol.64
, pp. 488-493
-
-
Herning, R.I.1
Better, W.E.2
Tate, K.3
Cadet, J.L.4
-
42
-
-
84865309293
-
The nature of dopamine dysfunction in schizophrenia and what this means for treatment
-
Howes O.D., Kambeitz J., Kim E., Stahl D., Slifstein M., Abi-Dargham A., Kapur S. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch. Gen. Psychiatry 2012, 69:776-786. 10.1001/archgenpsychiatry.2012.169.
-
(2012)
Arch. Gen. Psychiatry
, vol.69
, pp. 776-786
-
-
Howes, O.D.1
Kambeitz, J.2
Kim, E.3
Stahl, D.4
Slifstein, M.5
Abi-Dargham, A.6
Kapur, S.7
-
43
-
-
65349120160
-
The dopamine hypothesis of schizophrenia: version III-the final common pathway
-
Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 2009, 35:549-562. 10.1093/schbul/sbp006.
-
(2009)
Schizophr. Bull.
, vol.35
, pp. 549-562
-
-
Howes, O.D.1
Kapur, S.2
-
44
-
-
34548510337
-
Human cannabinoid pharmacokinetics
-
Huestis M.A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 2007, 10.1002/cbdv.200790152.
-
(2007)
Chem. Biodivers.
-
-
Huestis, M.A.1
-
45
-
-
0032590232
-
CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide
-
Kathmann M., Bauer U., Schlicker E. CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide. Naunyn. Schmiedebergs. Arch. Pharmacol. 1999, 360:421-427. 10.1007/s002109900091.
-
(1999)
Naunyn. Schmiedebergs. Arch. Pharmacol.
, vol.360
, pp. 421-427
-
-
Kathmann, M.1
Bauer, U.2
Schlicker, E.3
-
46
-
-
84866246492
-
Does olanzapine inhibit the psychomimetic effects of 9-tetrahydrocannabinol?
-
Kleinloog D., Liem-Moolenaar M., Jacobs G., Klaassen E., de Kam M., Hijman R., van Gerven J Does olanzapine inhibit the psychomimetic effects of 9-tetrahydrocannabinol?. J. Psychopharmacol. 2012, 10.1177/0269881112446534.
-
(2012)
J. Psychopharmacol.
-
-
Kleinloog, D.1
Liem-Moolenaar, M.2
Jacobs, G.3
Klaassen, E.4
de Kam, M.5
Hijman, R.6
van Gerven, J.7
-
47
-
-
84880810573
-
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18f-fallypride positron emission tomography study
-
Kuepper R., Ceccarini J., Lataster J., van Os J., van Kroonenburgh M., van Gerven J.M.A., Marcelis M., van Laere K., Henquet C. Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18f-fallypride positron emission tomography study. PLoS One 2013, 8. 10.1371/journal.pone.0070378.
-
(2013)
PLoS One
, pp. 8
-
-
Kuepper, R.1
Ceccarini, J.2
Lataster, J.3
van Os, J.4
van Kroonenburgh, M.5
van Gerven, J.M.A.6
Marcelis, M.7
van Laere, K.8
Henquet, C.9
-
48
-
-
77955054913
-
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines
-
Kuepper R., Morrison P.D., van Os J., Murray R.M., Kenis G., Henquet C. Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr. Res. 2010, 10.1016/j.schres.2010.05.031.
-
(2010)
Schizophr. Res.
-
-
Kuepper, R.1
Morrison, P.D.2
van Os, J.3
Murray, R.M.4
Kenis, G.5
Henquet, C.6
-
49
-
-
0030608782
-
Imaging D2 receptor occupancy by endogenous dopamine in humans
-
Laruelle M., D'Souza C.D., Baldwin R.M., Abi-Dargham A., Kanes S.J., Fingado C.L., Seibyl J.P., Zoghbi S.S., Bowers M.B., Jatlow P., Charney D.S., Innis R.B. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 1997, 17:162-174. 10.1016/S0893-133X(97)00043-2.
-
(1997)
Neuropsychopharmacology
, vol.17
, pp. 162-174
-
-
Laruelle, M.1
D'Souza, C.D.2
Baldwin, R.M.3
Abi-Dargham, A.4
Kanes, S.J.5
Fingado, C.L.6
Seibyl, J.P.7
Zoghbi, S.S.8
Bowers, M.B.9
Jatlow, P.10
Charney, D.S.11
Innis, R.B.12
-
50
-
-
84868210063
-
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study
-
Leroy C., Karila L., Martinot J.L., Lukasiewicz M., Duchesnay E., Comtat C., Dollé F., Benyamina A., Artiges E., Ribeiro M.J., Reynaud M., Trichard C. Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addict. Biol. 2012, 17:981-990. 10.1111/j.1369-1600.2011.00356.x.
-
(2012)
Addict. Biol.
, vol.17
, pp. 981-990
-
-
Leroy, C.1
Karila, L.2
Martinot, J.L.3
Lukasiewicz, M.4
Duchesnay, E.5
Comtat, C.6
Dollé, F.7
Benyamina, A.8
Artiges, E.9
Ribeiro, M.J.10
Reynaud, M.11
Trichard, C.12
-
51
-
-
0036897933
-
Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men
-
Leyton M., Boileau I., Benkelfat C., Diksic M., Baker G., Dagher A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 2002, 27:1027-1035. 10.1016/S0893-133X(02)00366-4.
-
(2002)
Neuropsychopharmacology
, vol.27
, pp. 1027-1035
-
-
Leyton, M.1
Boileau, I.2
Benkelfat, C.3
Diksic, M.4
Baker, G.5
Dagher, A.6
-
52
-
-
77955057652
-
Central nervous system effects of haloperidol on THC in healthy male volunteers
-
Liem-Moolenaar M., te Beek E.T., de Kam M.L., Franson K.L., Kahn R.S., Hijman R., Touw D., van Gerven J.M.A. Central nervous system effects of haloperidol on THC in healthy male volunteers. J. Psychopharmacol. 2010, 24:1697-1708. 10.1177/0269881109358200.
-
(2010)
J. Psychopharmacol.
, vol.24
, pp. 1697-1708
-
-
Liem-Moolenaar, M.1
te Beek, E.T.2
de Kam, M.L.3
Franson, K.L.4
Kahn, R.S.5
Hijman, R.6
Touw, D.7
van Gerven, J.M.A.8
-
53
-
-
4744351585
-
Marijuana and cannabinoid regulation of brain reward circuits
-
Lupica C.R., Riegel A.C., Hoffman A.F. Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol. 2004, 143:227-234. 10.1038/sj.bjp.0705931.
-
(2004)
Br. J. Pharmacol.
, vol.143
, pp. 227-234
-
-
Lupica, C.R.1
Riegel, A.C.2
Hoffman, A.F.3
-
54
-
-
84856409614
-
Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine
-
Machielsen M., Beduin A.S., Dekker N., Kahn R.S., Linszen D.H., van Os J., Wiersma D., Bruggeman R., Cahn W., de Haan L., Krabbendam L., Myin-Germeys I. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. J. Psychopharmacol. 2012, 10.1177/0269881111408957.
-
(2012)
J. Psychopharmacol.
-
-
Machielsen, M.1
Beduin, A.S.2
Dekker, N.3
Kahn, R.S.4
Linszen, D.H.5
van Os, J.6
Wiersma, D.7
Bruggeman, R.8
Cahn, W.9
de Haan, L.10
Krabbendam, L.11
Myin-Germeys, I.12
-
55
-
-
0019958135
-
Effects of acute cannabis use and short-term deprivation on plasma prolactin and dopamine-beta-hydroxylase in long-term users
-
Markianos M., Stefanis C. Effects of acute cannabis use and short-term deprivation on plasma prolactin and dopamine-beta-hydroxylase in long-term users. Drug Alcohol Depend. 1982, 9:251-255. 10.1016/0376-8716(82)90050-3.
-
(1982)
Drug Alcohol Depend.
, vol.9
, pp. 251-255
-
-
Markianos, M.1
Stefanis, C.2
-
56
-
-
0021691720
-
Effects of acute cannabis use on urinary neurotransmitter metabolites and cyclic nucleotides in man
-
Markianos M., Vakis A. Effects of acute cannabis use on urinary neurotransmitter metabolites and cyclic nucleotides in man. Drug Alcohol Depend. 1984, 14:175-178. 10.1016/0376-8716(84)90042-5.
-
(1984)
Drug Alcohol Depend.
, vol.14
, pp. 175-178
-
-
Markianos, M.1
Vakis, A.2
-
57
-
-
0015839227
-
Effect of cannabis sativa administered by smoking on biogenic amine excretion in man
-
Messiha F.S., Soskin R.A. Effect of cannabis sativa administered by smoking on biogenic amine excretion in man. Res. Commun. Chem. Pathol. Pharmacol. 1973, 6:325-328.
-
(1973)
Res. Commun. Chem. Pathol. Pharmacol.
, vol.6
, pp. 325-328
-
-
Messiha, F.S.1
Soskin, R.A.2
-
58
-
-
84900828695
-
Stress-Induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use
-
Mizrahi R., Kenk M., Suridjan I., Boileau I., George T.P., McKenzie K., Wilson A.a, Houle S., Rusjan P. Stress-Induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacology 2014, 39:1479-1489. 10.1038/npp.2013.347.
-
(2014)
Neuropsychopharmacology
, vol.39
, pp. 1479-1489
-
-
Mizrahi, R.1
Kenk, M.2
Suridjan, I.3
Boileau, I.4
George, T.P.5
McKenzie, K.6
Wilson, A.A.7
Houle, S.8
Rusjan, P.9
-
59
-
-
84873739013
-
Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-±PHNO
-
Mizrahi R., Suridjan I., Kenk M., George T.P., Wilson A., Houle S., Rusjan P. Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-±PHNO. Neuropsychopharmacology 2013, 38:673-682. 10.1038/npp.2012.232.
-
(2013)
Neuropsychopharmacology
, vol.38
, pp. 673-682
-
-
Mizrahi, R.1
Suridjan, I.2
Kenk, M.3
George, T.P.4
Wilson, A.5
Houle, S.6
Rusjan, P.7
-
60
-
-
34447619511
-
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
-
Moore T.H.M., Zammit S., Lingford-Hughes A., Barnes T.R.E., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328. 10.1016/S0140-6736(07)61162-3.
-
(2007)
Lancet
, vol.370
, pp. 319-328
-
-
Moore, T.H.M.1
Zammit, S.2
Lingford-Hughes, A.3
Barnes, T.R.E.4
Jones, P.B.5
Burke, M.6
Lewis, G.7
-
61
-
-
33646178948
-
Sex differences in striatal dopamine release in healthy adults
-
Munro C.A., McCaul M.E., Wong D.F., Oswald L.M., Zhou Y., Brasic J., Kuwabara H., Kumar A., Alexander M., Ye W., Wand G.S. Sex differences in striatal dopamine release in healthy adults. Biol. Psychiatry 2006, 59:966-974. 10.1016/j.biopsych.2006.01.008.
-
(2006)
Biol. Psychiatry
, vol.59
, pp. 966-974
-
-
Munro, C.A.1
McCaul, M.E.2
Wong, D.F.3
Oswald, L.M.4
Zhou, Y.5
Brasic, J.6
Kuwabara, H.7
Kumar, A.8
Alexander, M.9
Ye, W.10
Wand, G.S.11
-
62
-
-
0028362367
-
Cerebrospinal fluid study of cannabinoid users and normal control subjects
-
Musselmann D.L., Haden C., Caudle J., Kalin N.H., Lewine R.R.J., Risch S.C. Cerebrospinal fluid study of cannabinoid users and normal control subjects. Psychiatry Res. 1994, 52:103-105.
-
(1994)
Psychiatry Res.
, vol.52
, pp. 103-105
-
-
Musselmann, D.L.1
Haden, C.2
Caudle, J.3
Kalin, N.H.4
Lewine, R.R.J.5
Risch, S.C.6
-
63
-
-
0029064115
-
Relationships between motivation and depression in chronic marijuana users
-
Musty R.E., Kaback L. Relationships between motivation and depression in chronic marijuana users. Life Sci. 1995, 2151-2158. 10.1016/0024-3205(95)00202-H.
-
(1995)
Life Sci.
, pp. 2151-2158
-
-
Musty, R.E.1
Kaback, L.2
-
64
-
-
77951088919
-
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum
-
Narendran R., Mason N.S., Laymon C.M., Lopresti B.J., Velasquez N.D., May M.A., Kendro S., Martinez D., Mathis C.A., Frankle W.G. A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum. J. Pharmacol. Exp. Ther. 2010, 333:533-539. 10.1124/jpet.109.163501.
-
(2010)
J. Pharmacol. Exp. Ther.
, vol.333
, pp. 533-539
-
-
Narendran, R.1
Mason, N.S.2
Laymon, C.M.3
Lopresti, B.J.4
Velasquez, N.D.5
May, M.A.6
Kendro, S.7
Martinez, D.8
Mathis, C.A.9
Frankle, W.G.10
-
65
-
-
15444373514
-
Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine
-
Oswald L.M., Wong D.F., McCaul M., Zhou Y., Kuwabara H., Choi L., Brasic J., Wand G.S. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2005, 10.1038/sj.npp.1300667.
-
(2005)
Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol.
-
-
Oswald, L.M.1
Wong, D.F.2
McCaul, M.3
Zhou, Y.4
Kuwabara, H.5
Choi, L.6
Brasic, J.7
Wand, G.S.8
-
66
-
-
21344456178
-
Chronic drug exposures during development in nonhuman primates: models of brain dysfunction in humans
-
Paule M.G. Chronic drug exposures during development in nonhuman primates: models of brain dysfunction in humans. Front. Biosci. 2005, 10:2240-2249. 10.2741/1693.
-
(2005)
Front. Biosci.
, vol.10
, pp. 2240-2249
-
-
Paule, M.G.1
-
68
-
-
29244432491
-
The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
-
Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci. Biobehav. Rev. 2006, 10.1016/j.neubiorev.2005.04.016.
-
(2006)
Neurosci. Biobehav. Rev.
-
-
Pierce, R.C.1
Kumaresan, V.2
-
69
-
-
0036460442
-
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study
-
Pistis M., Muntoni A.L., Pillolla G., Gessa G.L. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Eur. J. Neurosci. 2002, 15:1795-1802. 10.1046/j.1460-9568.2002.02019.x.
-
(2002)
Eur. J. Neurosci.
, vol.15
, pp. 1795-1802
-
-
Pistis, M.1
Muntoni, A.L.2
Pillolla, G.3
Gessa, G.L.4
-
70
-
-
0034904322
-
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation
-
Pistis M., Porcu G., Melis M., Diana M., Gessa G.L. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. Eur. J. Neurosci. 2001, 14:96-102. 10.1046/j.0953-816X.2001.01612.x.
-
(2001)
Eur. J. Neurosci.
, vol.14
, pp. 96-102
-
-
Pistis, M.1
Porcu, G.2
Melis, M.3
Diana, M.4
Gessa, G.L.5
-
71
-
-
0018954391
-
Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes
-
Poddar M.K., Dewey W.L. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes. J. Pharmacol. Exp. Ther. 1980, 214:63-67.
-
(1980)
J. Pharmacol. Exp. Ther.
, vol.214
, pp. 63-67
-
-
Poddar, M.K.1
Dewey, W.L.2
-
72
-
-
84886774491
-
Effects of acute detoxification of the herbal blend "Spice Gold" on dopamine D2/3 receptor availability: a [18F]fallypride PET study
-
Rominger A., Cumming P., Xiong G., Koller G., Förster S., Zwergal A., Karamatskos E., Bartenstein P., La Fougère C., Pogarell O. Effects of acute detoxification of the herbal blend "Spice Gold" on dopamine D2/3 receptor availability: a [18F]fallypride PET study. Eur. Neuropsychopharmacol. 2013, 23:1606-1610. 10.1016/j.euroneuro.2013.01.009.
-
(2013)
Eur. Neuropsychopharmacol.
, vol.23
, pp. 1606-1610
-
-
Rominger, A.1
Cumming, P.2
Xiong, G.3
Koller, G.4
Förster, S.5
Zwergal, A.6
Karamatskos, E.7
Bartenstein, P.8
La Fougère, C.9
Pogarell, O.10
-
73
-
-
79958009477
-
Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study
-
Safont G., Corripio I., Escartí M.J., Portella M.J., Pérez V., Ferrer M., Camacho V., Sauras R.B., Alonso A., Grasa E.M., Arranz B., San L., Dueñas R., Carrió I., Álvarez E. Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study. Schizophr. Res. 2011, 129:169-171. 10.1016/j.schres.2011.03.012.
-
(2011)
Schizophr. Res.
, vol.129
, pp. 169-171
-
-
Safont, G.1
Corripio, I.2
Escartí, M.J.3
Portella, M.J.4
Pérez, V.5
Ferrer, M.6
Camacho, V.7
Sauras, R.B.8
Alonso, A.9
Grasa, E.M.10
Arranz, B.11
San, L.12
Dueñas, R.13
Carrió, I.14
Álvarez, E.15
-
74
-
-
79956062589
-
Cannabis use disorder and age at onset of psychosis-a study in first-episode patients
-
Schimmelmann B.G., Conus P., Cotton S.M., Kupferschmid S., Karow A., Schultze-Lutter F., McGorry P.D., Lambert M. Cannabis use disorder and age at onset of psychosis-a study in first-episode patients. Schizophr. Res. 2011, 129:52-56. 10.1016/j.schres.2011.03.023.
-
(2011)
Schizophr. Res.
, vol.129
, pp. 52-56
-
-
Schimmelmann, B.G.1
Conus, P.2
Cotton, S.M.3
Kupferschmid, S.4
Karow, A.5
Schultze-Lutter, F.6
McGorry, P.D.7
Lambert, M.8
-
75
-
-
0030608801
-
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus
-
Schlicker E., Timm J., Zentner J., Göthert M. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn. Schmiedebergs. Arch. Pharmacol. 1997, 356:583-589. 10.1007/PL00005093.
-
(1997)
Naunyn. Schmiedebergs. Arch. Pharmacol.
, vol.356
, pp. 583-589
-
-
Schlicker, E.1
Timm, J.2
Zentner, J.3
Göthert, M.4
-
76
-
-
41849112002
-
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography
-
Sevy S., Smith G.S., Ma Y., Dhawan V., Chaly T., Kingsley P.B., Kumra S., Abdelmessih S., Eidelberg D. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology 2008, 197:549-556. 10.1007/s00213-008-1075-1.
-
(2008)
Psychopharmacology
, vol.197
, pp. 549-556
-
-
Sevy, S.1
Smith, G.S.2
Ma, Y.3
Dhawan, V.4
Chaly, T.5
Kingsley, P.B.6
Kumra, S.7
Abdelmessih, S.8
Eidelberg, D.9
-
77
-
-
84855342146
-
Within-subject comparison of [11C]-(+)-PHNO and [11C]raclopride sensitivity to acute amphetamine challenge in healthy humans
-
Shotbolt P., Tziortzi A.C., Searle G.E., Colasanti A., van der Aart J., Abanades S., Plisson C., Miller S.R., Huiban M., Beaver J.D., Gunn R.N., Laruelle M., Rabiner E.A. Within-subject comparison of [11C]-(+)-PHNO and [11C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J. Cereb. Blood Flow Metab. 2012, 10.1038/jcbfm.2011.115.
-
(2012)
J. Cereb. Blood Flow Metab.
-
-
Shotbolt, P.1
Tziortzi, A.C.2
Searle, G.E.3
Colasanti, A.4
van der Aart, J.5
Abanades, S.6
Plisson, C.7
Miller, S.R.8
Huiban, M.9
Beaver, J.D.10
Gunn, R.N.11
Laruelle, M.12
Rabiner, E.A.13
-
78
-
-
0017277759
-
The dopamine hypothesis of schizophrenia: focus on the dopamine receptor
-
Snyder S.H. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am. J. Psychiatry 1976, 133:197-202. 10.1093/schbul/2.1.19.
-
(1976)
Am. J. Psychiatry
, vol.133
, pp. 197-202
-
-
Snyder, S.H.1
-
79
-
-
2342632473
-
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex
-
Steffens M., Engler C., Zentner J., Feuerstein T.J. Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. Br. J. Pharmacol. 2004, 141:1193-1203. 10.1038/sj.bjp.0705706.
-
(2004)
Br. J. Pharmacol.
, vol.141
, pp. 1193-1203
-
-
Steffens, M.1
Engler, C.2
Zentner, J.3
Feuerstein, T.J.4
-
80
-
-
84856437355
-
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability
-
Stokes P.R., Egerton A., Watson B., Reid A., Lappin J., Howes O.D., Nutt D.J., Lingford-Hughes A.R. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. J. Psychopharmacol. 2012, 10.1177/0269881111414090.
-
(2012)
J. Psychopharmacol.
-
-
Stokes, P.R.1
Egerton, A.2
Watson, B.3
Reid, A.4
Lappin, J.5
Howes, O.D.6
Nutt, D.J.7
Lingford-Hughes, A.R.8
-
81
-
-
77954958645
-
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge
-
Stokes P.R.A., Egerton A., Watson B., Reid A., Breen G., Lingford-Hughes A., Nutt D.J., Mehta M.A. Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage 2010, 52:1521-1527. 10.1016/j.neuroimage.2010.04.274.
-
(2010)
Neuroimage
, vol.52
, pp. 1521-1527
-
-
Stokes, P.R.A.1
Egerton, A.2
Watson, B.3
Reid, A.4
Breen, G.5
Lingford-Hughes, A.6
Nutt, D.J.7
Mehta, M.A.8
-
82
-
-
67949121758
-
Can recreational doses of THC produce significant dopamine release in the human striatum?
-
Stokes P.R.A., Mehta M.A., Curran H.V., Breen G., Grasby P.M. Can recreational doses of THC produce significant dopamine release in the human striatum?. Neuroimage 2009, 48:186-190. 10.1016/j.neuroimage.2009.06.029.
-
(2009)
Neuroimage
, vol.48
, pp. 186-190
-
-
Stokes, P.R.A.1
Mehta, M.A.2
Curran, H.V.3
Breen, G.4
Grasby, P.M.5
-
83
-
-
0141451977
-
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data
-
Tanda, G., Goldberg, S.R., 2003. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology. 10.1007/s00213-003-1485-z.
-
(2003)
Psychopharmacology
-
-
Tanda, G.1
Goldberg, S.R.2
-
84
-
-
0030761521
-
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism
-
Tanda G., Pontieri F.E., Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997, 276:2048-2050. 10.1126/science.276.5321.2048.
-
(1997)
Science
, vol.276
, pp. 2048-2050
-
-
Tanda, G.1
Pontieri, F.E.2
Di Chiara, G.3
-
85
-
-
84890551498
-
-
World Drug Report 2013. Joost 2013.
-
United Nations Office on Drugs and Crime, 2013. World Drug Report 2013. Joost 2013, 316. doi:10.1002/yd.20002.
-
(2013)
, pp. 316
-
-
-
86
-
-
84862776963
-
Dopamine release in chronic cannabis users: a [11C]raclopride positron emission tomography study
-
Urban N.B.L., Slifstein M., Thompson J.L., Xu X., Girgis R.R., Raheja S., Haney M., Abi-Dargham A. Dopamine release in chronic cannabis users: a [11C]raclopride positron emission tomography study. Biol. Psychiatry 2012, 71:677-683. 10.1016/j.biopsych.2011.12.018.
-
(2012)
Biol. Psychiatry
, vol.71
, pp. 677-683
-
-
Urban, N.B.L.1
Slifstein, M.2
Thompson, J.L.3
Xu, X.4
Girgis, R.R.5
Raheja, S.6
Haney, M.7
Abi-Dargham, A.8
-
87
-
-
45849099117
-
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial
-
Van Nimwegen L.J., de Haan L., van Beveren N.J., van der Helm M., van den Brink W., Linszen D. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Can. J. Psychiatry 2008, 53:400-405.
-
(2008)
Can. J. Psychiatry
, vol.53
, pp. 400-405
-
-
Van Nimwegen, L.J.1
de Haan, L.2
van Beveren, N.J.3
van der Helm, M.4
van den Brink, W.5
Linszen, D.6
-
88
-
-
79951472497
-
Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up
-
Van Winkel R. Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch. Gen. Psychiatry 2011, 68:148-157. 10.1001/archgenpsychiatry.2010.152.
-
(2011)
Arch. Gen. Psychiatry
, vol.68
, pp. 148-157
-
-
Van Winkel, R.1
-
89
-
-
84897446932
-
Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis
-
Van Winkel R., Kuepper R. Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis. Annu. Rev. Clin. Psychol. 2014, 10:767-791. 10.1146/annurev-clinpsy-032813-153631.
-
(2014)
Annu. Rev. Clin. Psychol.
, vol.10
, pp. 767-791
-
-
Van Winkel, R.1
Kuepper, R.2
-
90
-
-
84885857705
-
A longitudinal analysis of the effects of a DRD4 polymorphism on marijuana use
-
Vaske J., Boisvert D., Wright J.P., Beaver K.M. A longitudinal analysis of the effects of a DRD4 polymorphism on marijuana use. Psychiatry Res. 2013, 210:247-255. 10.1016/j.psychres.2013.04.022.
-
(2013)
Psychiatry Res.
, vol.210
, pp. 247-255
-
-
Vaske, J.1
Boisvert, D.2
Wright, J.P.3
Beaver, K.M.4
-
91
-
-
84904962560
-
Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity
-
Volkow N.D., Wang G.-J., Telang F., Fowler J.S., Alexoff D., Logan J., Jayne M., Wong C., Tomasi D. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc. Natl. Acad. Sci. 2014, 1411228111. 10.1073/pnas.1411228111.
-
(2014)
Proc. Natl. Acad. Sci.
, pp. 1411228111
-
-
Volkow, N.D.1
Wang, G.-J.2
Telang, F.3
Fowler, J.S.4
Alexoff, D.5
Logan, J.6
Jayne, M.7
Wong, C.8
Tomasi, D.9
-
92
-
-
0035479031
-
Cannabis induced dopamine release: an in-vivo SPECT study
-
Voruganti L.N.P., Slomka P., Zabel P., Mattar A., Awad A.G. Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res. - Neuroimaging 2001, 107:173-177. 10.1016/S0925-4927(01)00104-4.
-
(2001)
Psychiatry Res. - Neuroimaging
, vol.107
, pp. 173-177
-
-
Voruganti, L.N.P.1
Slomka, P.2
Zabel, P.3
Mattar, A.4
Awad, A.G.5
-
93
-
-
0036513612
-
Systems to rate the strength of scientific evidence
-
doi:AHRQ Publication No. 02-E016
-
West S., King V., Carey T.S., Lohr K.N., McKoy N., Sutton S.F., Lux L. Systems to rate the strength of scientific evidence. Evid. Rep. Technol. Assess. (Summ). 2002, 1-11. doi:AHRQ Publication No. 02-E016.
-
(2002)
Evid. Rep. Technol. Assess. (Summ).
, pp. 1-11
-
-
West, S.1
King, V.2
Carey, T.S.3
Lohr, K.N.4
McKoy, N.5
Sutton, S.F.6
Lux, L.7
-
95
-
-
55949128528
-
Effects of cannabis use on outcomes of psychotic disorders: systematic review
-
Zammit S., Moore T.H.M., Lingford-Hughes A., Barnes T.R.E., Jones P.B., Burke M., Lewis G. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br. J. Psychiatry 2008, 193:357-363. 10.1192/bjp.bp.107.046375.
-
(2008)
Br. J. Psychiatry
, vol.193
, pp. 357-363
-
-
Zammit, S.1
Moore, T.H.M.2
Lingford-Hughes, A.3
Barnes, T.R.E.4
Jones, P.B.5
Burke, M.6
Lewis, G.7
|